Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-26
DOI
10.1111/jgh.15787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On the proposed definition of metabolic associated fatty liver disease
- (2021) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2021) Haleh Chehrehgosha et al. Diabetes Therapy
- Endorsing the redefinition of fatty liver disease
- (2021) Soek Siam Tan et al. Lancet Gastroenterology & Hepatology
- Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD
- (2021) Gong Feng et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
- (2021) Yu‐Jie Zhou et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
- (2021) Katsutoshi Tokushige et al. JOURNAL OF GASTROENTEROLOGY
- Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need
- (2021) Yu-Jie Zhou et al. Hepatobiliary Surgery and Nutrition
- Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- (2021) Thaninee Prasoppokakorn et al. Journal of Clinical and Translational Hepatology
- Modelling NAFLD disease burden in four Asian regions-2019-2030
- (2020) Chris Estes et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes
- (2020) Kenneth Cusi DIABETES CARE
- Pioglitazone and bladder cancer: improving research methods
- (2020) E. Ripamonti et al. DIABETIC MEDICINE
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
- (2020) Shu-ting Wang et al. BMC GASTROENTEROLOGY
- Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease
- (2020) Feng Gao et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
- (2020) Feng‐Bin Lu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Health Literacy Research in Malaysia: A Scoping Review
- (2020) Adina Abdullah et al. Sains Malaysiana
- Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
- (2020) Leon A. Adams et al. SEMINARS IN LIVER DISEASE
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Validation of Baveno VI and expanded Baveno VI criteria to identify high-risk varices in patients with MAFLD-related compensated cirrhosis
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
- (2020) Hayatul Najaa Miptah et al. BMC Family Practice
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
- (2020) Alessandro Mantovani et al. GUT
- Relationship between dietary patterns and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
- (2020) Shirin Hassani Zadeh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease
- (2020) Margarita Papatheodoridi et al. JOURNAL OF HEPATOLOGY
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
- (2020) Erik J. Tillman et al. Frontiers in Endocrinology
- When a new definition overhauls perceptions of MAFLD related cirrhosis care
- (2020) Kenneth I. Zheng et al. Hepatobiliary Surgery and Nutrition
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis
- (2019) Susana G. Rodrigues et al. Clinical Gastroenterology and Hepatology
- Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
- (2019) Vincent Wai-Sun Wong et al. GUT
- MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis
- (2019) Kee‐Huat Chuah et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis
- (2019) Wah-Kheong Chan et al. Clinical Gastroenterology and Hepatology
- Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-risk Varices in Patients with Chronic Liver Diseases: A Systematic Review and Meta-analysis
- (2019) Maria Stafylidou et al. Clinical Gastroenterology and Hepatology
- New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
- (2019) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Pioglitazone: inexpensive; very effective at reducing HbA 1c ; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit
- (2019) Robert E. J. Ryder et al. DIABETIC MEDICINE
- Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
- (2019) Stanley Khoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram
- (2019) Yu-Jie Zhou et al. United European Gastroenterology Journal
- A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
- (2019) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- The impact of hepatic steatosis on portal hypertension
- (2019) Georg Semmler et al. PLoS One
- A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease
- (2019) Muhammad Izzad Johari et al. Scientific Reports
- Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial
- (2019) Hua Cai et al. BMC GASTROENTEROLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
- (2019) Francesco De Chiara et al. Nutrients
- Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
- (2018) J. Boursier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
- (2018) W.-K. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis
- (2018) Melina Utz-Melere et al. Annals of Hepatology
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis
- (2018) Mayer B. Davidson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Lifestyle interventions for patients with nonalcoholic fatty liver disease
- (2018) Tian-Tian Zou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The Effectiveness of Self-Management Interventions for Individuals with Low Health Literacy and/or Low Income: A Descriptive Systematic Review
- (2018) Jamie Schaffler et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Incorporating a structural approach to reducing the burden of non-communicable diseases
- (2018) Joshua S. Yang et al. Globalization and Health
- Pioglitazone and bladder cancer risk: a systematic review and meta-analysis
- (2018) Huilin Tang et al. Cancer Medicine
- Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
- (2018) Huaqing Yan et al. Cancer Management and Research
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
- (2018) Jaehee Ahn et al. CLINICAL NUTRITION
- Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
- (2018) Simona Leoni et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Evidence on the effectiveness of health literacy interventions in the EU: a systematic review
- (2018) Boudewijn B. Visscher et al. BMC PUBLIC HEALTH
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis
- (2018) Tannous K. Fakhry et al. Surgery for Obesity and Related Diseases
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2017) Charlie C. Park et al. GASTROENTEROLOGY
- Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
- (2017) Salvador Augustin et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies
- (2017) Fabrice Bonnet et al. JOURNAL OF HYPERTENSION
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD)
- (2016) Ratree Sawangjit et al. MEDICINE
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
- (2015) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Effect of pretransplant diabetes on short-term outcomes after liver transplantation: A National cohort study
- (2015) Richard S. Hoehn et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease: Portal Hypertension Due to Outflow Block in Patients without Cirrhosis
- (2015) Masashi Hirooka et al. RADIOLOGY
- Pentoxifylline for the treatment of nonalcoholic fatty liver disease
- (2014) Tao Zeng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis
- (2014) Wah-Kheong Chan et al. Hepatology International
- Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries
- (2014) Ke-Qing Shi et al. MOLECULAR BIOLOGY REPORTS
- Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis
- (2013) Xiaofei Wang et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia
- (2013) Wah-Kheong Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- JIS Definition Identified More Malaysian Adults with Metabolic Syndrome Compared to the NCEP-ATP III and IDF Criteria
- (2013) Anis Safura Ramli et al. Biomed Research International
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease
- (2012) Flavia D. Mendes et al. Clinical Gastroenterology and Hepatology
- Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia
- (2012) Seok-Chin Goh et al. Hepatology International
- Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus
- (2012) Anuradhani Kasturiratne et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2012) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
- (2011) Yusuke Kawamura et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- (2011) Vincent Wai-Sun Wong et al. GUT
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
- (2008) K Kantartzis et al. GUT
- Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
- (2008) Satoru Yatsuji et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search